CN1141934C - Health-care oil for regulating blood fat - Google Patents
Health-care oil for regulating blood fat Download PDFInfo
- Publication number
- CN1141934C CN1141934C CNB001134698A CN00113469A CN1141934C CN 1141934 C CN1141934 C CN 1141934C CN B001134698 A CNB001134698 A CN B001134698A CN 00113469 A CN00113469 A CN 00113469A CN 1141934 C CN1141934 C CN 1141934C
- Authority
- CN
- China
- Prior art keywords
- oil
- blood fat
- health
- regulating
- care oil
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Abstract
The present invention discloses health-care oil for regulating blood fat, which comprises the raw materials of the weight percentage: 20 to 60% of popular edible oil made from vegetable seeds, 10 to 50% of rice bran oil, 3 to 30% of sunflower seed oil and 2 to 30% of evening primrose oil. The raw materials are metered, filtered, proportioned, filtered, charged with nitrogen and packed to form finished products. The health-care oil reasonably regulates the fatty acid content of lipid and sufficiently utilizes lipid which has a high nutrient value and is easy to obtain for achieving the purpose of regulating the blood fat of human bodies.
Description
Technical field:
The present invention relates to a kind of nutrition oil, specifically is a kind of blood lipid regulation health care oil.
Background technology:
Along with the development of social civilization, the sickness rate of cardiovascular and cerebrovascular disease increases day by day, and it replaces cancer and becomes the No.1 killer who jeopardizes the human life, and the metabolism of the generation of these diseases and people's edible fat has extremely important relation.Studies show that, edible linoleic acid, the linolenic oils and fats energy blood fat reducing concentration of being rich in, especially gamma-Linolenic acid has the blood fat of preventing deposition, anticoagulant, prevents effects such as cerebral tissue is aging.For a long time, people are human consumption soybeans, Semen Brassicae campestris, single oils and fats such as Semen arachidis hypogaeae, single oils and fats is owing to composition is not difficult to guarantee the necessary nutrition of human body entirely, a lot of mixed oils on the present market, it also only is a kind of simple mediation, mainly from local flavor, commercial angle goes to consider, nutritionally do not do too much research, therefore its health care also is far from being, having occurred some in recent years relates to and prevents cardio-cerebrovascular disease, and the health edible oil of energy brain-strengthening and memory reinforcing, mainly form by a-linolenic acid (ester) and oil with common edible, but it is unreasonable that some oil fatty acid is formed, be of high nutritive value for some simultaneously, the oils and fats that is easy to obtain fails to be made full use of, as Testa oryzae oil, safflower oil, Semen Allii Tuberosi wet goods not only fatty acid is formed rationally, also contain oryzanol simultaneously, sterol, compositions such as vitamin E, these materials are for reducing the human serum cholesterol, prevent and treat cardiovascular disease good effect is arranged.
Summary of the invention
The purpose of this invention is to provide a kind of reasonable lipid regulating fatty acid and form, make oil fatty acid meet the human body needs, make full use of the oils and fats that some are of high nutritive value and are easy to obtain, to regulate the blood lipid regulation health care oil of human body blood fat.
The object of the present invention is achieved like this: blood lipid regulation health care oil of the present invention is in harmonious proportion by following component and content and forms (consumption is weight percentage):
Popular edible oil 20%～60%, Testa oryzae oil 10%～50%, safflower oil 3%～30%, oenothera odorata oil 2%～30%.
Preferred weight proportioning (percentage ratio) scope of blood lipid regulation health care oil of the present invention is:
Popular edible oil 30%～50%, Testa oryzae oil 20%～40%, safflower oil 5%～20%, oenothera odorata oil 5%～15%.
The optimum weight proportioning (percentage ratio) of blood lipid regulation health care oil of the present invention is:
Popular edible oil 40%, Testa oryzae oil 35%, safflower oil 15%, oenothera odorata oil 10%.
Above-mentioned each component raw material is made blood lipid regulation health care oil of the present invention, and its preparation method adopts the conventional preparation method of prior art mixed oil, is about to each raw material by the prescription metering, filter, stir down fully at room temperature (room temperature) and to be in harmonious proportion, after the filtration, fill nitrogen, packing the oily finished product of health care.
Blood lipid regulation health care oil of the present invention rationally lipid regulating fatty acid is formed, and makes oil fatty acid meet the needs of health.Make full use of the important physiological function of microcomponent such as oryzanol, vitamin E in the function such as blood fat reducing of about 10% the gamma-Linolenic acid that contains in the oenothera odorata oil and Testa oryzae oil, safflower oil, the Semen Allii Tuberosi wet goods oil simultaneously, to reach the purpose of regulating the human body blood fat, abundant Oleum Brassicae campestris or soybean oil, Oleum Helianthi, the popular edible oil resource of Semen arachidis hypogaeae wet goods have been made full use of again.This product form is a plant blend oil in bulk, can be used as daily life with oil, also can make forms such as capsule or fat-reducing food, with as nutrient and healthcare products.
Following zoopery shows that its effect for reducing blood fat, effect are particularly remarkable.
This prescription carries out zoopery through the specified College of Applied Arts ﹠ Sciences of BJ Union University of Ministry of Public Health, the healthy secondary Wistar that the experiment white mouse provides with Institute of Experimental Animals, Chinese Academy of Medical Sciences's breeding field, rat is taken above-mentioned prescription vegetable oil after three weeks, serum total cholesterol, serum triglycerides situation of change such as following table, as can be seen from the table: the oil of this prescription has tangible hypolipemic function.
This prescription oils and fats is to the influence of Wistar rat blood serum cholesterol (TC) (X ± SD)
*: relatively there were significant differences (P＜0.05) with high fat matched group
*: relatively there were significant differences (P＜0.01) with high fat matched group
* *: with high fat matched group relatively there were significant differences (P＜0.001) ###: with relatively there were significant differences (P＜0.001) before the experiment this prescription oils and fats to the influence of Wistar rat blood serum triglyceride (TG) (X ± SD)
| Group | Number of animals (only) | TC(mmol/L) | |||
| To before being tried thing | P value (comparing) with normal group | Tried thing after 3 weeks | P value (comparing) with high fat group | ||
| The normal control group | 14 | 1.72±0.19 | - | 1.60±0.11 *** | 1.1510 |
| High fat matched group | 14 | 1.71±0.18 | 0.8337 | 2.72±0.50### | - |
| Low dose group | 14 | 1.79±0.38 | 0.5483 | 2.31±0.26 * | 0.0123 |
| Middle dosage group | 14 | 1.69±0.21 | 0.6315 | 2.23±0.23 ** | 0.0026 |
| High dose group | 14 | 1.71±0.24 | 0.8765 | 2.05±0.42 *** | 0.0007 |
| Group | Number of animals (only) | TC(mmol/L) | |||
| To before being tried thing | P value (comparing) with normal group | Tried thing after 3 weeks | P value (comparing) with high fat group | ||
| The normal control group | 14 | 0.74±0.28 | 0.74±0.16 | ||
| High fat matched group | 14 | 0.75±0.26 | 0.8743 | 1.10±0.24## | |
| Low dose group | 14 | 0.70±0.19 | 0.7025 | 0.94±0.18 | 0.0623 |
| Middle dosage group | 14 | 0.73±0.14 | 0.9785 | 0.83±0.25 ** | 0.0076 |
| High dose group | 14 | 0.74±0.10 | 0.9990 | 0.59±0.16 *** | 6.910 |
*: with high fat matched group relatively there were significant differences (P＜0.01
* *: relatively there were significant differences (P＜0.001) with high fat matched group
##: with relatively there were significant differences (P＜0.01) before the experiment
The specific embodiment:
The invention will be further described below in conjunction with embodiment, and still, the present invention is not limited only to these examples.
Embodiment one:
Take by weighing and filter back refined rapeseed oil 6.0kg, Testa oryzae oil 2.0kg, safflower oil 1.0kg, oenothera odorata oil 1.0kg after room temperature (room temperature) fully mixes down, fills the nitrogen fill.
Embodiment two:
Take by weighing and filter back refined rapeseed oil 3.0kg, Testa oryzae oil 4.0kg, safflower oil 1.5kg, oenothera odorata oil 1.5kg after room temperature (room temperature) fully mixes down, fills the nitrogen fill.
Embodiment three:
Take by weighing and filter back refined rapeseed oil 4.0kg, Testa oryzae oil 3.5kg, safflower oil 1.5kg, oenothera odorata oil 1.0kg after room temperature (room temperature) fully mixes down, fills the nitrogen fill.
Claims (1)
1, a kind of blood lipid regulation health care oil, the percentage ratio of its material component and content (percentage by weight) is:
Oleum Brassicae campestris 30%～50%, Testa oryzae oil 20%～40%, safflower oil 5%～20%, oenothera odorata oil 5%～15%.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB001134698A CN1141934C (en) | 2000-05-26 | 2000-05-26 | Health-care oil for regulating blood fat |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB001134698A CN1141934C (en) | 2000-05-26 | 2000-05-26 | Health-care oil for regulating blood fat |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1298698A CN1298698A (en) | 2001-06-13 |
| CN1141934C true CN1141934C (en) | 2004-03-17 |
Family
ID=4583249
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNB001134698A Expired - Fee Related CN1141934C (en) | 2000-05-26 | 2000-05-26 | Health-care oil for regulating blood fat |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1141934C (en) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103468391B (en) * | 2013-09-10 | 2015-11-25 | 滁州金恒油脂工业有限公司定远县金恒油厂 | A kind of preparation method consolidating foster kidney sunflower seed oil |
| CN103651962A (en) * | 2013-11-22 | 2014-03-26 | 安徽大平油脂有限公司 | Menstruation-regulating and qi-tonifying health oil |
| CN103931792A (en) * | 2014-03-21 | 2014-07-23 | 安徽省怀远县鑫泰粮油有限公司 | Cardiovascular and cerebrovascular disease preventing peanut oil and its preparation method |
| CN105661542A (en) * | 2016-01-19 | 2016-06-15 | 吉林金恒制药股份有限公司 | Lipid-reducing healthcare oil |
-
2000
- 2000-05-26 CN CNB001134698A patent/CN1141934C/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| CN1298698A (en) | 2001-06-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN105053276B (en) | Preparation method without sucrose functionality peony seed oil powdered oil | |
| CN100562254C (en) | A kind of plant blend oil | |
| CN102224858B (en) | Blend oil for special dietary | |
| DE69818704T2 (en) | METHOD FOR IMPROVING THE ABSORPTION AND TRANSPORT OF LIPID-SOLUBLE COMPOUNDS BY MEANS OF STRUCTURED GLYCERIDES | |
| CN105104584B (en) | The preparation method of peony seed oil powdered oil containing active peptide | |
| CN103444911A (en) | Medicinal and edible health care blending oil | |
| CN105053256A (en) | Flavored nutrition balanced blend oil | |
| WO1999033355A2 (en) | Fat blend | |
| CN101720822A (en) | Nutritional blend oil with balanced fatty acid component and active component for middle and old aged | |
| EP0755633B1 (en) | Two phases preparation | |
| CN107105745A (en) | The nutrient fat acid composition of optimization | |
| CN103190619A (en) | Fish oil and linseed oil soft capsules and preparation method thereof | |
| CN104171025A (en) | Selenium-rich edible oil suitable for women and children | |
| CN107683909A (en) | The special ready-mixed oil of high fat diet | |
| CN105918497A (en) | Blend oil with healthcare function and preparation method thereof | |
| CN102578307A (en) | Dual-sub-acid high-end vegetable oil and preparation method thereof | |
| Tereshchuk | Theoretical and practical aspects of the development of a balanced lipid complex of fat compositions | |
| CN110353056A (en) | A kind of edible vegetable blend oil | |
| CN101099562A (en) | Omega-3 unsaturated fatty acids appetizer oil and producing method and application thereof | |
| CN106578139A (en) | Rapeseed oil for invigorating brain and application of rapeseed oil | |
| CN1298647A (en) | Health-care oil for regulating blood fat | |
| KR100724165B1 (en) | Natural vegetable oil concentrated in unsaponifiable matters as food ingredient | |
| CN1141934C (en) | Health-care oil for regulating blood fat | |
| CN109527579A (en) | A kind of application of surprise Asia seed oil product and preparation method thereof and the sub- seed oil product of the surprise | |
| Lee | Essent ial Fat ty Acids |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C06 | Publication | ||
| PB01 | Publication | ||
| C53 | Correction of patent for invention or patent application | ||
| CB02 | Change of applicant information |
Applicant after: Jinjia Rice Industry Co., Ltd., Hu'nan Applicant before: Jinjan Rice Industry Co., Ltd., Hu'nan |
|
| COR | Change of bibliographic data |
Free format text: CORRECT: APPLICANT; FROM: JINJIAN RICE INDUSTRY STOCK CO., LTD., HUNAN TO: JINJIAN RICE INDUSTRY STOCK CO., LTD., HUNAN |
|
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C19 | Lapse of patent right due to non-payment of the annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |